EyeGate Announces First Patient Enrolled in PRK Pivotal Study

Go back to EyeGate Announces First Patient Enrolled in PRK Pivotal Study
(NASDAQ: EYEG) Delayed: 34.57 -0.06 (0.17%)
Previous Close $34.63    52 Week High $5.09 
Open $34.57    52 Week Low $1.11 
Day High $34.57    P/E N/A 
Day Low $34.57    EPS $0.00 
Volume 59